Detection of severe aortic stenosis by clinicians versus artificial intelligence: A retrospective clinical cohort study
Many severe aortic stenosis (AS) cases are undetected and/or not considered for potentially life-saving treatment, with a persistent male-bias reported among those undergoing aortic valve replacement (AVR). We evaluated the clinical value of a validated artificial intelligence automated alert system (AI-AAS) that detects severe AS from routine echocardiographic measurements. In a retrospective, clinical cohort of 21,749 adults investigated with transthoracic echocardiography at two tertiary-referral centres, we identified 4057 women (aged 61.6 ± 18.1 years) and 5132 men (60.8 ± 17.5 years) with native aortic valves. We firstly applied the AI-AAS to the cardiologists' reported echo measurements, to detect all AS cases, including guideline-defined severe AS. Two expert clinicians then independently reviewed the original clinical diagnosis/management based on the initial report. Initially, 218/9189 (2.4 %, 95%CI 2.1-2.7 %) severe AS cases were diagnosed. The AI-AAS subsequently increased this number by 158 (52 % women) to 376 cases (4.1 %, 95%CI 3.7-4.5 %) of severe guideline-defined AS. Overall, more women were under-diagnosed (92/169 [54.4 %] versus 80/207 [38.6 %] men - adjusted odds ratio [aOR] 0.21, 95%CI 0.10-0.45). Even when accounting for potential contraindications to valvular intervention, women were persistently less likely to be considered for valvular intervention (aOR 0.54, 95%CI 0.31-0.95) and/or underwent AVR (aOR 0.29, 95%CI 0.09-0.74). Our study suggests an AI-AAS application that is agnostic to gender, haemodynamic bias, symptoms, or clinical factors, provides an objective alert to severe forms of AS (including guideline-defined severe AS) following a routine echocardiogram, and has the potential to increase the number of people (especially women) directed towards more definitive treatment/specialist care.
Authors
- Michael P. Feneley (ORCID: https://orcid.org/0000-0002-6650-8865)
- Simon Stewart (ORCID: https://orcid.org/0000-0001-9032-8998)
- Y. Situ
- David L. Prior (ORCID: https://orcid.org/0000-0002-3243-7026)
- David Playford (ORCID: https://orcid.org/0000-0003-4492-1103)
- Prasanna Venkataraman (ORCID: https://orcid.org/0000-0002-8603-1734)
- Geoffrey A. Strange
- David Cardona Müller (ORCID: https://orcid.org/0000-0001-5072-7943)
Institutions
- The University of Sydney (AU)
- The University of Melbourne (AU)
- St Vincent's Hospital Melbourne (AU)
- St Vincent's Hospital Sydney (AU)
- University of Glasgow (GB)
- The University of Notre Dame Australia (AU)
Publication Details
- Journal
- American Heart Journal Plus Cardiology Research and Practice
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1016/j.ahjo.2024.100485
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Edwards Lifesciences
- National Health and Medical Research Council